Clinical information

Resources

Videos for clinicians to learn more about Arthrosamid®, a new class of injectable therapy to treat knee osteoarthritis patients.

If you cannot find the content you need here, please contact us.

Arthrosamid BASK 2023Play icon
0:15

BASK 2023 Congress - Introducing Arthrosamid® a new class of injectable therapy to treat knee osteoarhritis

The team attended the BASK 2023 Congress to discuss a new injectable class of therapy to treat patients with knee osteoarthritis.

Arthrosamid® is a new type of treatment injected into the knee to help treat the pain caused by knee osteoarthritis, offering an alternative to currently available therapies.

A recent study presented at the OARSI 2023 World Congress has demonstrated that a single injection of 6 ml 2.5% polyacrylamide #hydrogel, Arthrosamid®, maintained a statistically significant reduction in pain in patients with knee osteoarthritis (OA) 3 years after treatment.

Arthrosamid Event Follow Up October 2022Play icon
0:35

BOA 2022 Congress and London Knee Meeting Summary

We attended the BOA2022 Congress and London Knee Meeting this month to introduce Arthrosamid®, a new class of therapy for patients with knee osteoarthritis. the coming month, we will attend the Bristol/Oxford Uni Knee Meeting and Wexham Cruciate 2022.

BASK 2022 Conference Arthrosamy by Contura OrthopaedicsPlay icon
0:30

BASK 2022 - Introducing Arthrosamid®, a new class of injectable therapy to treat knee OA



BASK 2022 Conference Arthrosamy by Contura OrthopaedicsPlay icon
0:15

BASK 2022 - Introducing Arthrosamid®, a new class of injectable therapy to treat knee OA

Arthrosamid® by Contura Orthopaedics is an intra-articular polyacrylamide hydrogel injection (iPAAG). It is a non-biodegradable single-dose injection that delivers long-acting and sustained pain relief, improving the quality of life for patients with knee osteoarthritis.

ESSKA 2022 Arthrosamid by Contura OrrthopaedicsPlay icon
1:30

ESSKA 2022 - Introducing Arthrosamid®, a new class of injectable therapy to treat knee OA

BOA ThumbnailPlay icon
27:04

BOA 2021 - Arthrosamid® by Contura Orthopaedics Ltd - The Knee OA Treatment 20 Years in the Making

Contura Orthopaedics Sponsored Session at BOA 2021 - Presentation on Arthrosamid® by Contura Orthopaedics Ltd - The Knee OA Treatment 20 Years in the Making - Whole Presentation

IAS Thumnail BOAPlay icon
12:26

Dr Ieva Ankorina Stark Hydrogel BOA 2021

Contura Sponsored Session at BOA 2021 - Presentation on Arthrosamid Novel OA Treatment - Product Information

HB Thumnail BOAPlay icon
07:54

Prof Henning Bliddal BOA 2021

Contura Sponsored Session at BOA 2021 - Presentation on Arthrosamid Novel OA Treatment Clinical Results

Thumbnail Prof Phil Conaghan OARSI 2021Play icon
05:11

Prof Phil Conaghan OARSI 2021

Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Introduction on Intraarticular OA treatments

Thumbnail OARSI 2021 Emerging data on a new class of knee OA therapyPlay icon
27:04

OARSI 2021 Emerging data on a new class of knee OA therapy

Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Whole Presentation

Thumbnail Dr Ieva Ankorina Stark Hydrogel OARSI 2021Play icon
12:26

Dr Ieva Ankorina Stark Hydrogel OARSI 2021

Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Product Information

Thumbnail Prof Henning Bliddal OARSI 2021Play icon
07:54

Prof Henning Bliddal OARSI 2021

Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment Clinical Results

Healthcare Professionals

The website you are requesting is intended for healthcare professionals. By continuing, you are confirming you are a healthcare professional. If you are not a healthcare professional, please return to our home page.